BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8365828)

  • 1. Anti-CD3-induced T-cell activation--II. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Neumann CM; Oughton JA; Kerkvliet NI
    Int J Immunopharmacol; 1993 May; 15(4):543-50. PubMed ID: 8365828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD3-induced T-cell activation in vivo--I. Flow cytometric analysis of dose-responsive, time-dependent, and cyclosporin A-sensitive parameters of CD4+ and CD8+ cells from the draining lymph nodes of C57Bl/6 mice.
    Neumann CM; Oughton JA; Kerkvliet NI
    Int J Immunopharmacol; 1992 Oct; 14(7):1295-304. PubMed ID: 1452414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production.
    Prell RA; Oughton JA; Kerkvliet NI
    Int J Immunopharmacol; 1995 Nov; 17(11):951-61. PubMed ID: 8788124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity in peripheral T cells.
    Camacho IA; Hassuneh MR; Nagarkatti M; Nagarkatti PS
    Toxicology; 2001 Aug; 165(1):51-63. PubMed ID: 11551431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of apoptosis in activated and resting T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its repercussion on T cell responsiveness.
    Pryputniewicz SJ; Nagarkatti M; Nagarkatti PS
    Toxicology; 1998 Aug; 129(2-3):211-26. PubMed ID: 9772099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin co-stimulates staphylococcal enterotoxin beta (SEB) cytokine production and phenotypic cell cycling in Long-Evans rats.
    Huang W; Koller LD
    Int J Immunopharmacol; 1998; 20(1-3):39-56. PubMed ID: 9717081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4(+) T cells: the roles of apoptosis, Fas, and TNF.
    Dearstyne EA; Kerkvliet NI
    Toxicology; 2002 Jan; 170(1-2):139-51. PubMed ID: 11750091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells.
    Camacho IA; Nagarkatti M; Nagarkatti PS
    Arch Toxicol; 2002 Oct; 76(10):570-80. PubMed ID: 12373453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits the activation of antigen-specific T-cells in mice.
    Lundberg K; Dencker L; Grönvik KO
    Int J Immunopharmacol; 1992 May; 14(4):699-705. PubMed ID: 1521937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor.
    Zhang L; Ma J; Takeuchi M; Usui Y; Hattori T; Okunuki Y; Yamakawa N; Kezuka T; Kuroda M; Goto H
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2109-17. PubMed ID: 20007828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Kerkvliet NI; Brauner JA
    Environ Res; 1990 Aug; 52(2):146-54. PubMed ID: 2118453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Fas apoptosis and MHC genes in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity of T cells.
    Rhile MJ; Nagarkatti M; Nagarkatti PS
    Toxicology; 1996 Jun; 110(1-3):153-67. PubMed ID: 8658555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
    Kerkvliet NI; Shepherd DM; Baecher-Steppan L
    Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporin A on the anti-CD3 antibody- and concanavalin A-induced activation and membrane potential of human T lymphocytes.
    Gergely P; Aszalos A
    Immunopharmacology; 1990; 20(3):191-9. PubMed ID: 2149721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTL hyporesponsiveness induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis.
    Prell RA; Dearstyne E; Steppan LG; Vella AT; Kerkvliet NI
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):214-21. PubMed ID: 10906285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro.
    Lang DS; Becker S; Clark GC; Devlin RB; Koren HS
    Arch Toxicol; 1994; 68(5):296-302. PubMed ID: 8085940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Camacho IA; Nagarkatti M; Nagarkatti PS
    Toxicol Sci; 2004 Mar; 78(1):96-106. PubMed ID: 14718643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superantigen-primed T cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) replicate poorly following recall encounter.
    Faulconer L; Camacho I; Nagarkatti M; Nagarkatti PS
    Arch Toxicol; 2006 Mar; 80(3):134-45. PubMed ID: 16189661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and behavior of the Ah receptor in murine T lymphocytes.
    Lawrence BP; Leid M; Kerkvliet NI
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):275-84. PubMed ID: 8658529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.